Please login to the form below

Not currently logged in
Email:
Password:

Hume Brophy launches new life science division

Will provide a targeted approach to healthcare communications

Hume BrophyPublic and corporate affairs agency Hume Brophy has launched a new life sciences arm to its international healthcare business.

Hume Brophy Life Sciences will provide a targeted approach to healthcare communications and further help their clients navigate “highly-regulated complexities of the vibrant life science market across Europe”.

Drawing in ‘experts’ from across the medical communications, science, academia, media, pharma and biotech fields, the team will develop and deliver advocacy platforms, strategic communications and market planning programmes.

The new practice will be led by Hume Brophy International Healthcare’s managing director Conor Griffin.

He said: “In an increasingly competitive, fast-changing and cost-sensitive healthcare industry we have put together a multidisciplinary team of science, media, regulatory and policy experts that can translate the complex challenges facing healthcare innovators into tailored strategic communication programmes to highlight the often unmet needs for an increasingly demanding society.”

The practice will operate from all Hume Brophy offices, including London, Brussels, Dublin, New York, Paris, Hong Kong and Singapore.

Article by
Gemma Jones

1st March 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics